Cargando…
A Marked Low-Grade Inflammation and a Significant Deterioration in Metabolic Status in First-Episode Schizophrenia: A Five-Year Follow-Up Study
The objective of this study was to evaluate how schizophrenia spectrum disorders and applied long-term (5.1 years) antipsychotic (AP) treatment affect the serum level of acylcarnitines (ACs), cytokines and metabolic biomarkers and to characterize the dynamics of inflammatory and metabolic changes in...
Autores principales: | Parksepp, Madis, Haring, Liina, Kilk, Kalle, Taalberg, Egon, Kangro, Raul, Zilmer, Mihkel, Vasar, Eero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610466/ https://www.ncbi.nlm.nih.gov/pubmed/36295885 http://dx.doi.org/10.3390/metabo12100983 |
Ejemplares similares
-
The Expanded Endocannabinoid System Contributes to Metabolic and Body Mass Shifts in First-Episode Schizophrenia: A 5-Year Follow-Up Study
por: Parksepp, Madis, et al.
Publicado: (2022) -
Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease
por: Parksepp, Madis, et al.
Publicado: (2020) -
Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients
por: Kriisa, Kärt, et al.
Publicado: (2016) -
Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis
por: Koido, Kati, et al.
Publicado: (2016) -
Treatment With Lipopolysaccharide Induces Distinct Changes in Metabolite Profile and Body Weight in 129Sv and Bl6 Mouse Strains
por: Piirsalu, Maria, et al.
Publicado: (2020)